COMMITTED
TO EXCEPTIONAL ACCESS

PAYERS COVER RINVOQ after the trial of 1 TNFi (branded or biosimilar) with ~99 percent PREFERRED COMBINED COMMERCIAL AND MEDICARE PART D COVERAGE. National Commercial and Medicare Part D formulary coverage under the pharmacy benefit as of November 2025 in RA, PsA, AS, and nr-axSpA.

What Can Preferred Coverage Mean for Your RA,
PsA, AS, nr-axSpA, and GCA Patients?

PREFERRED* Coverage Means

  • RINVOQ is covered as a first-line therapy for GCA, and after the trial of 1 TNFi (branded or biosimilar) for RA, PsA, AS, and nr‑axSpA, ahead of non-preferred products
  • At the lowest branded copay/coinsurance tier

When you enroll patients at the time of prescription

provides you with a dedicated field reimbursement
manager and supports you throughout the prescription journey

Dedicated Point of Contact:
Field Reimbursement Managers help you and your patients navigate access—with case-by-case, personalized support to prevent delays and denials.

360° Access Support:
Comprehensive informational resources available to help coordinate reimbursement and fulfillment.

Patient Affordability‡

96% of commercial claims
for a filled
RINVOQ
prescription cost patients5‡
$0

Your eligible, commercially insured patients may pay as little as $0 per month with the RINVOQ Complete Savings Card.§

‡Based upon paid commercial claims data from national data providers for a filled RINVOQ prescription for RA, PsA, AS, nr-axSpA, and GCA for the period 5/2025-4/2026, inclusive of savings card redemptions.5


Patient’s actual out-of-pocket cost may vary depending on their insurance coverage and eligibility for support programs.

*RINVOQ is on a preferred tier or otherwise has preferred status on the plan's formulary.

†Coverage requirements and benefit designs vary by payer and may change over time. Please consult with payers directly for the most current reimbursement policies.

§RINVOQ Complete Savings Card Terms and Conditions Eligibility: Available to patients with commercial insurance coverage for RINVOQ® (upadacitinib) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com or call 1.800.2RINVOQ for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.

AS=ankylosing spondylitis; IR=intolerance or inadequate response; GCA=giant cell arteritis; nr-axSpA=non-radiographic axial spondyloarthritis; PsA=psoriatic arthritis; RA=rheumatoid arthritis; TNFi=tumor necrosis factor inhibitor

Check the Formulary Status for RINVOQ in Your Area

Formulary Zipcode


Select a filter

Choose Indication

Please enter a valid zip code.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Formulary Status Results

  • Plan Name
  • Plan Type
  • Status

Results ends here

  • Plan Name
  • Plan Type
  • Status

Results ends here

Preferred means RINVOQ is on a preferred tier or otherwise has preferred status on the plan’s formulary.

AS=active ankylosing spondylitis*; IR=intolerance or inadequate response; nr-axSpA=active non-radiographic axial spondyloarthritis†; PsA=active psoriatic arthritis*; RA=moderate to severe rheumatoid arthritis*; TNFi=tumor necrosis factor inhibitor

*In adult TNFi-IR patients.

†In adult TNFi-IR patients with objective signs of inflammation.

What could your patients pay for RINVOQ?

ANTHONY

COMMERCIALLY INSURED

As an eligible, commercially insured patient, Anthony pays $0 per month for his RINVOQ prescription.*

Find out how

CHERYL

MEDICARE PART D

As a standard Medicare Part D patient enrolled in the Medicare Prescription Payment Plan, Cheryl pays $200 per month for all her prescriptions.6

Find out how

JOEY

MEDICARE PART D
WITH EXTRA HELP

As a Medicare Part D Extra Help patient, Joey pays $14.40 per prescription for RINVOQ.6

Find out how

Final patient out-of-pocket costs may vary based on a number of factors, including but not limited to a patient's insurance coverage,
plan design, and Medicare Extra Help qualified enrollment.

*RINVOQ Complete Savings Card Terms and Conditions Eligibility: Available to patients with commercial insurance coverage for RINVOQ® (upadacitinib) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com or call 1.800.2RINVOQ for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.

Enroll your patients in

after prescribing RINVOQ for
exceptional 1:1 support